Cannabidiol for Treatment Resistant Epilepsy in Tuberous Sclerosis Patients

What we are studying

A research study to determine the efficacy of cannabidiol as an add-on treatment for people with tuberous sclerosis and seizures.

Who is Eligible

  • Genders:
    • Men
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 2 - 65

Eligibility Criteria

  • More than 8 seizures per month. A confirmed diagnosis of tuberous sclerosis.

What is involved

  • Multiple visits to the clinical research unit with blood draws
  • EKG and vital signs. Keeping detailed diaries of seizures.

Compensation

For travel.

Contact Information

Study Coordinator
Patricia Brown
Email
patrbrow@wakehealth.edu
Phone
336 7163460

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.